Focal palmoplantar keratoderma with joint keratoses
foh-kuhl pahm-oh-plan-tahr ker-uh-toh-der-muh with joint ker-uh-toh-seez
Also known as: Focal PPK with joint keratoses, Circumscribed palmoplantar keratoderma
At a Glance
What is Focal palmoplantar keratoderma with joint keratoses?
Focal palmoplantar keratoderma with joint keratoses is a rare genetic skin disorder. It primarily affects the skin on the palms of the hands and the soles of the feet. The condition is caused by mutations in specific genes that affect skin cell growth. Over time, thickened patches of skin, known as keratoses, develop on these areas and sometimes around the joints. Early symptoms include small, localized areas of thickened skin, which can become more widespread and pronounced as the individual ages. Early diagnosis is important to manage symptoms and prevent complications like skin infections. The condition can be challenging for families, as it may require ongoing medical care and lifestyle adjustments. Prognosis varies, but many individuals can manage symptoms with appropriate treatment. Daily life may involve regular use of emollients and protective measures to reduce discomfort. The disorder does not typically affect life expectancy. However, it can impact quality of life due to physical discomfort and potential social stigma. Support from healthcare providers and patient communities can be beneficial for affected individuals and their families.
Medical Definition
Focal palmoplantar keratoderma with joint keratoses is characterized by localized hyperkeratosis on the palms and soles, often extending to the skin overlying joints. Pathologically, it involves abnormal keratinocyte proliferation and differentiation. Histological findings include thickened stratum corneum and acanthosis. It is classified under hereditary palmoplantar keratodermas, with an autosomal dominant inheritance pattern. Epidemiologically, it is an extremely rare condition with limited cases reported worldwide. The disease course is chronic and progressive, with symptoms often appearing in childhood and worsening with age.
Focal palmoplantar keratoderma with joint keratoses Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Palmoplantar keratoderma manifests as thickened skin on the palms and soles. This occurs due to abnormal keratinization of the epidermis, leading to excessive skin growth. Over time, the thickening can become more pronounced and may develop fissures. It can significantly impact daily life by causing pain during walking or manual tasks, and management includes emollients and keratolytic agents.
Joint keratoses appear as thickened, wart-like lesions over the joints. These occur due to localized hyperkeratosis, where the skin produces excess keratin. The lesions may increase in size and number over time, potentially limiting joint movement. They can cause discomfort during physical activities, and treatment may involve topical retinoids or surgical removal.
Painful fissures are deep cracks in the thickened skin, often occurring on the soles. These result from the rigidity and reduced elasticity of hyperkeratotic skin. Fissures can deepen and become more painful without treatment, potentially leading to secondary infections. They can severely affect mobility, and management includes moisturizing, protective dressings, and sometimes antibiotics.
Common
Hyperhidrosis is characterized by excessive sweating, particularly on the palms and soles. This is due to overactive sweat glands, which can be exacerbated by the thickened skin. Over time, it may lead to maceration of the skin and increased risk of infections. It can cause social embarrassment and discomfort, and treatments include antiperspirants and botulinum toxin injections.
Itching is a common symptom associated with skin thickening and dryness. It occurs due to irritation of nerve endings in the skin, often exacerbated by environmental factors. If persistent, it can lead to scratching and further skin damage. It affects sleep and quality of life, and can be managed with antihistamines and topical corticosteroids.
Calluses are areas of thickened skin that develop due to repeated friction or pressure. They form as a protective response of the skin to mechanical stress. Over time, calluses can become painful and may crack. They can interfere with daily activities, and management includes mechanical debridement and protective padding.
Less Common
Nail abnormalities may include thickening, discoloration, or ridging of the nails. These changes occur due to altered keratinization affecting the nail matrix. Over time, nails may become brittle and prone to splitting. They can affect hand function and appearance, and treatment focuses on nail care and topical therapies.
Skin infections can occur due to breaks in the skin barrier from fissures or maceration. Bacteria or fungi can invade these areas, leading to localized infections. Without treatment, infections can spread and cause systemic symptoms. They can complicate the underlying condition, requiring antibiotics or antifungal medications for management.
What Causes Focal palmoplantar keratoderma with joint keratoses?
Focal palmoplantar keratoderma with joint keratoses is primarily caused by mutations in the AAGAB gene located on chromosome 15q22.33. The AAGAB gene encodes the alpha- and gamma-adaptin-binding protein p34, which plays a crucial role in the clathrin-mediated endocytosis pathway. Specific mutations in AAGAB lead to the production of a truncated or misfolded protein, impairing its ability to interact with adaptin proteins. This disruption affects the formation of clathrin-coated vesicles, leading to defective endocytosis and trafficking of membrane proteins. As a result, there is an accumulation of proteins and lipids in the cell membrane, causing cellular stress and dysfunction. Neighboring keratinocytes and fibroblasts are affected, leading to abnormal keratinization and thickening of the skin. The immune response is activated due to cellular stress, contributing to local inflammation and further tissue damage. Neuroinflammation may also occur, though its role in this condition is less defined. Degeneration of skin structures, such as the epidermis and dermis, occurs due to chronic inflammation and disrupted cellular homeostasis. Symptoms appear primarily in the palms and soles due to the high mechanical stress and unique keratin composition in these areas. Joint keratoses occur due to similar mechanical and cellular stress in joint regions. The severity of the disease varies among patients, likely due to differences in mutation types, genetic background, and environmental factors. Some patients may have additional symptoms, such as hearing loss, due to the involvement of similar cellular pathways in other tissues. Understanding the precise molecular mechanisms remains an active area of research, with ongoing studies aiming to elucidate the full spectrum of AAGAB-related pathologies.
How is Focal palmoplantar keratoderma with joint keratoses Diagnosed?
Typical age of diagnosis: Focal palmoplantar keratoderma with joint keratoses is typically diagnosed in early childhood when symptoms first become apparent, often due to noticeable skin changes and joint issues. Diagnosis may be delayed if symptoms are mild or attributed to more common conditions. Early recognition is crucial for management and to prevent complications. Genetic counseling is recommended for families with a history of the condition.
Clinicians look for thickened skin on the palms and soles, as well as keratoses around the joints. A detailed family history is important to identify any genetic predisposition. Physical examination reveals localized hyperkeratosis and potential joint involvement. This step helps differentiate the condition from other forms of keratoderma and guides further testing.
X-rays or MRI may be used to assess joint involvement and rule out other joint pathologies. Imaging can reveal joint space narrowing or other abnormalities consistent with keratoses. These findings help confirm the diagnosis by correlating skin and joint symptoms. Imaging also helps exclude conditions like arthritis or other dermatological disorders.
Blood tests may be ordered to rule out inflammatory or autoimmune conditions. Biomarkers such as inflammatory markers are typically normal in this condition. Abnormal results would prompt investigation for other diagnoses. Normal laboratory findings support the diagnosis of focal palmoplantar keratoderma with joint keratoses.
Genetic testing focuses on sequencing genes known to be associated with keratoderma, such as KRT1 or KRT9. Mutations in these genes, often missense or nonsense, confirm the diagnosis. Genetic results provide definitive confirmation and guide family counseling regarding inheritance patterns. They also help assess the risk for future offspring and inform family planning decisions.
Focal palmoplantar keratoderma with joint keratoses Treatment Options
Keratolytic agents like salicylic acid work by breaking down keratin, reducing skin thickness. Specific drugs used include topical salicylic acid and urea-based creams. Clinical evidence supports their efficacy in reducing hyperkeratosis and improving skin texture. Limitations include potential skin irritation and the need for regular application. Side effects are generally mild but can include redness and peeling.
Techniques focus on improving joint mobility and reducing discomfort. Therapeutic goals include maintaining function and preventing joint stiffness. Sessions are typically conducted weekly and adjusted based on patient progress. Measurable outcomes include improved range of motion and decreased pain. Long-term benefits include enhanced quality of life and reduced disability.
Surgery is indicated for severe cases where conservative measures fail. The procedure involves removing thickened skin to relieve symptoms. Expected benefits include reduced pain and improved mobility. Surgical risks include infection and scarring. Post-operative care involves wound management and monitoring for complications.
The care team includes dermatologists, geneticists, and physical therapists. Interventions focus on skin care, joint management, and genetic counseling. Psychosocial support strategies address emotional and social challenges. Family education is crucial for understanding the condition and managing daily care. Long-term monitoring involves regular follow-ups to assess treatment efficacy and adjust care plans.
When to See a Doctor for Focal palmoplantar keratoderma with joint keratoses
- Severe pain in the joints — this could indicate a significant inflammatory process or joint damage that requires immediate medical attention.
- Sudden loss of mobility — this may suggest a severe progression of the condition or a related complication that needs urgent evaluation.
- Signs of infection such as redness, warmth, or pus around keratoses — these symptoms could indicate a bacterial infection that requires prompt treatment.
- Persistent joint stiffness — this could lead to reduced mobility and should be evaluated by a healthcare provider to prevent further complications.
- Worsening of skin lesions — changes in the appearance or size of keratoses may require medical assessment to adjust treatment plans.
- Hearing difficulties — as hearing loss can be associated with this condition, any changes should be investigated by an audiologist.
- Mild discomfort in the palms or soles — monitor for any changes in severity or appearance, and use recommended topical treatments.
- Occasional joint aches — keep track of frequency and intensity, and discuss with a doctor during routine visits if they become more frequent.
Focal palmoplantar keratoderma with joint keratoses — Frequently Asked Questions
Is this condition hereditary?
Focal palmoplantar keratoderma with joint keratoses is typically inherited in an autosomal dominant pattern. This means there is a 50% chance of passing it to children if one parent is affected. De novo mutations can occur, meaning the condition can appear without a family history. Carrier status is not applicable as the condition is not recessive. Genetic counseling is recommended for affected individuals and their families to understand inheritance patterns and risks.
What is the life expectancy for someone with this condition?
Life expectancy for individuals with this condition is generally normal, although quality of life can be affected. Prognosis may vary depending on the age of onset and severity of symptoms. Complications such as joint damage or infections can worsen outcomes if not managed properly. Effective treatment and management of symptoms can improve quality of life and prevent complications. Realistic expectations include managing symptoms and maintaining a good quality of life with appropriate care.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis typically involves a clinical evaluation by a dermatologist and may include genetic testing. The time from first symptoms to diagnosis can vary, often taking several months to years due to the rarity of the condition. Specialists involved may include dermatologists, geneticists, and rheumatologists. Delayed diagnosis is common due to symptom overlap with other conditions and lack of awareness. Confirmation is usually achieved through genetic testing and clinical assessment.
Are there any new treatments or clinical trials available?
Research is ongoing, with promising studies focusing on gene therapy and targeted treatments. Novel approaches aim to address the genetic basis of the condition and improve symptom management. ClinicalTrials.gov is a resource for finding current trials, and discussing options with your doctor is advised. Patients should inquire about eligibility for trials and potential benefits versus risks. New treatments may become available in the next few years, but timelines can vary.
How does this condition affect daily life and activities?
The condition can impact mobility and self-care due to pain and stiffness in the joints and thickened skin. Educational and occupational activities may be affected, requiring adaptations. Social and emotional challenges include coping with visible skin changes and potential hearing loss. Family members may experience a caregiving burden, necessitating support. Adaptive devices, physical therapy, and counseling can significantly aid in managing daily life.
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.[Familial circumscribed plantar keratosis with sensorineural hearing loss and sporadic CHILD syndrome].
Gloor M, Gross M, Happle R et al. · Hautarzt · 1989 · PMID: 2525542
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-04-27